Galapagos NV (GLPG)
NASDAQ: GLPG · Real-Time Price · USD
28.43
-0.04 (-0.14%)
At close: Apr 28, 2026, 4:00 PM EDT
28.42
-0.01 (-0.04%)
After-hours: Apr 28, 2026, 4:10 PM EDT
Galapagos NV Employees
Galapagos NV had 704 employees as of December 31, 2024. The number of employees decreased by 419 or -37.31% compared to the previous year.
Employees
704
Change (1Y)
-419
Growth (1Y)
-37.31%
Revenue / Employee
$2,340,350
Profits / Employee
$675,192
Market Cap
1.87B
Employees Chart
Employees History
Related Stocks
| Company Name | Employees |
|---|---|
| Recursion Pharmaceuticals | 600 |
| Vericel | 398 |
| Syndax Pharmaceuticals | 298 |
| Harmony Biosciences Holdings | 293 |
| Capricor Therapeutics | 231 |
| Pharvaris | 129 |
| Inhibrx Biosciences | 110 |
| AnaptysBio | 104 |
GLPG News
- 4 weeks ago - Galapagos NV Transcript: Collaboration - Transcripts
- 4 weeks ago - Galapagos Enters Framework Agreement With Gilead In Connection With Ouro Deal - Nasdaq
- 4 weeks ago - Galapagos NV: Galapagos and Gilead Enter into Binding Agreement to Collaborate on Advancing First in Class T Cell Engager Program for Autoimmune Diseases - Finanz Nachrichten
- 4 weeks ago - Galapagos and Gilead Enter into Binding Agreement to Collaborate on Advancing First in Class T Cell Engager Program for Autoimmune Diseases - GlobeNewsWire
- 4 weeks ago - Galapagos NV: Galapagos Publishes 2025 Annual Report and Announces Annual and Extraordinary Shareholders' Meetings - Finanz Nachrichten
- 4 weeks ago - Galapagos NV: Galapagos Announces Nomination of Gino Santini to its Board of Directors - Finanz Nachrichten
- 4 weeks ago - Galapagos Announces Nomination of Gino Santini to its Board of Directors - GlobeNewsWire
- 4 weeks ago - Galapagos Publishes 2025 Annual Report and Announces Annual and Extraordinary Shareholders' Meetings - GlobeNewsWire